Tag: non-medication switching
By Michael Wong, JD (Founder/Executive Director, Physician-Patient Alliance for Health & Safety)
This is a modern-day story of David and Goliath of how a patient took on CVS Caremark and won.
In the biblical version, David with just a staff, sling, and stones, fights the giant Goliath and wins.
Continue reading “How a Patient Battled with CVS Caremark and Won” →
Patient health and safety advocates and the biopharmaceutical industry share a commitment to improve patient care and safety to removing obstacles to physician-prescribed medications. At the recent BIO Patient and Health Advocacy Summit, advocates and industry met to discuss these shared concerns. Representatives from the Physician-Patient Alliance for Health & Safety attended the Summit.
There were two major key concerns discussed:
Continue reading “Obstacles to Physician-Prescribed Medications – Cost, Delays, and Denials” →
Michael Wong, JD (founder and executive director of the Physician-Patient Alliance for Health & Safety) spoke about the liabilities of non-medication switching and other insurer practices, such as prior authorizations and step therapies, at the Cardiometabolic Health Congress, which took place from October 24-27, 2018. Speaking with Mr. Wong were:
Continue reading “The Liabilities of Non-Medication Switching and Other Insurer Practices” →